The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Bone and Mineral Metabolism Disorders Treatment-Global Market Insights and Sales Trends 2024
Synopsis
Bone minerals are the inorganic compounds of the bone tissue that helps in strengthening the bones with its plate and globular structures. These minerals are formed from carbonated hydroxyapatite. Bone minerals are dynamic in living beings, it is continuously reabsorbed and build anew in the bone remodelling process. Bone functions as storehouse of calcium, from which calcium is continuously withdrawn or stored as a part of homeostasis. Bone mineral metabolism is refers to the maintenance of sufficient concentration of inorganic ions in blood serum irrespective of muscle tissue metabolic activities. Hormones such as parathormone and calcitonin plays vital role in controlling the muscle metabolic activities, these hormones are regulated by neuroendocrine system and produced by parathyroid and thyroid glands in the neck. Malfunction of these glands result in to metabolic in equilibrium and crates the problems of bone mineral metabolism. Bone and mineral density metabolic disorders are abnormalities of bones, caused by calcium, phosphorous, magnesium and vitamin D aberrations leading to several reversible clinical disorders. These disorders are generally treatable if the underlining cause is addressed with corrective treatment methods. These disorders are caused due to genetic or metabolic malfunctions in the body.
The global Bone and Mineral Metabolism Disorders Treatment market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Bone and Mineral Metabolism Disorders Treatment in various end use industries. The expanding demands from the Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and Drug Stores, are propelling Bone and Mineral Metabolism Disorders Treatment market. Bisphosphonates, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Estrogens segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Bone and Mineral Metabolism Disorders Treatment, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Bone and Mineral Metabolism Disorders Treatment market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Bone and Mineral Metabolism Disorders Treatment market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Bone and Mineral Metabolism Disorders Treatment sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Bone and Mineral Metabolism Disorders Treatment covered in this report include Merck, F. Hoffmann-La Roche, Novartis, Warner Chilcott, Sanofi, AbbVie and Amgen, etc.
The global Bone and Mineral Metabolism Disorders Treatment market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Merck
F. Hoffmann-La Roche
Novartis
Warner Chilcott
Sanofi
AbbVie
Amgen
Global Bone and Mineral Metabolism Disorders Treatment market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Bone and Mineral Metabolism Disorders Treatment market, Segment by Type:
Bisphosphonates
Estrogens
Phosphate Binders
Non-Calcium, Non-Metal-Based Binder
Metal-Based Binders
Magnesium-Based Binders
Vitamin D Analogs and Supplements
Calcimimetic Agents
Calcium and Magnesium Supplements
Global Bone and Mineral Metabolism Disorders Treatment market, by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Drug Stores
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Bone and Mineral Metabolism Disorders Treatment companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Bone minerals are the inorganic compounds of the bone tissue that helps in strengthening the bones with its plate and globular structures. These minerals are formed from carbonated hydroxyapatite. Bone minerals are dynamic in living beings, it is continuously reabsorbed and build anew in the bone remodelling process. Bone functions as storehouse of calcium, from which calcium is continuously withdrawn or stored as a part of homeostasis. Bone mineral metabolism is refers to the maintenance of sufficient concentration of inorganic ions in blood serum irrespective of muscle tissue metabolic activities. Hormones such as parathormone and calcitonin plays vital role in controlling the muscle metabolic activities, these hormones are regulated by neuroendocrine system and produced by parathyroid and thyroid glands in the neck. Malfunction of these glands result in to metabolic in equilibrium and crates the problems of bone mineral metabolism. Bone and mineral density metabolic disorders are abnormalities of bones, caused by calcium, phosphorous, magnesium and vitamin D aberrations leading to several reversible clinical disorders. These disorders are generally treatable if the underlining cause is addressed with corrective treatment methods. These disorders are caused due to genetic or metabolic malfunctions in the body.
The global Bone and Mineral Metabolism Disorders Treatment market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Bone and Mineral Metabolism Disorders Treatment in various end use industries. The expanding demands from the Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and Drug Stores, are propelling Bone and Mineral Metabolism Disorders Treatment market. Bisphosphonates, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Estrogens segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Bone and Mineral Metabolism Disorders Treatment, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Bone and Mineral Metabolism Disorders Treatment market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Bone and Mineral Metabolism Disorders Treatment market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Bone and Mineral Metabolism Disorders Treatment sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Bone and Mineral Metabolism Disorders Treatment covered in this report include Merck, F. Hoffmann-La Roche, Novartis, Warner Chilcott, Sanofi, AbbVie and Amgen, etc.
The global Bone and Mineral Metabolism Disorders Treatment market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Merck
F. Hoffmann-La Roche
Novartis
Warner Chilcott
Sanofi
AbbVie
Amgen
Global Bone and Mineral Metabolism Disorders Treatment market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Bone and Mineral Metabolism Disorders Treatment market, Segment by Type:
Bisphosphonates
Estrogens
Phosphate Binders
Non-Calcium, Non-Metal-Based Binder
Metal-Based Binders
Magnesium-Based Binders
Vitamin D Analogs and Supplements
Calcimimetic Agents
Calcium and Magnesium Supplements
Global Bone and Mineral Metabolism Disorders Treatment market, by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Drug Stores
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Bone and Mineral Metabolism Disorders Treatment companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Bone and Mineral Metabolism Disorders Treatment
1.1 Bone and Mineral Metabolism Disorders Treatment Market Overview
1.1.1 Bone and Mineral Metabolism Disorders Treatment Product Scope
1.1.2 Bone and Mineral Metabolism Disorders Treatment Market Status and Outlook
1.2 Global Bone and Mineral Metabolism Disorders Treatment Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Bone and Mineral Metabolism Disorders Treatment Market Size by Region (2018-2029)
1.4 Global Bone and Mineral Metabolism Disorders Treatment Historic Market Size by Region (2018-2023)
1.5 Global Bone and Mineral Metabolism Disorders Treatment Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Bone and Mineral Metabolism Disorders Treatment Market Size (2018-2029)
1.6.1 North America Bone and Mineral Metabolism Disorders Treatment Market Size (2018-2029)
1.6.2 Europe Bone and Mineral Metabolism Disorders Treatment Market Size (2018-2029)
1.6.3 Asia-Pacific Bone and Mineral Metabolism Disorders Treatment Market Size (2018-2029)
1.6.4 Latin America Bone and Mineral Metabolism Disorders Treatment Market Size (2018-2029)
1.6.5 Middle East & Africa Bone and Mineral Metabolism Disorders Treatment Market Size (2018-2029)
2 Bone and Mineral Metabolism Disorders Treatment Market by Type
2.1 Introduction
2.1.1 Bisphosphonates
2.1.2 Estrogens
2.1.3 Phosphate Binders
2.1.4 Non-Calcium, Non-Metal-Based Binder
2.1.5 Metal-Based Binders
2.1.6 Magnesium-Based Binders
2.1.7 Vitamin D Analogs and Supplements
2.1.8 Calcimimetic Agents
2.1.9 Calcium and Magnesium Supplements
2.2 Global Bone and Mineral Metabolism Disorders Treatment Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Bone and Mineral Metabolism Disorders Treatment Historic Market Size by Type (2018-2023)
2.2.2 Global Bone and Mineral Metabolism Disorders Treatment Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Bone and Mineral Metabolism Disorders Treatment Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Bone and Mineral Metabolism Disorders Treatment Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Bone and Mineral Metabolism Disorders Treatment Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Bone and Mineral Metabolism Disorders Treatment Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Bone and Mineral Metabolism Disorders Treatment Revenue Breakdown by Type (2018-2029)
3 Bone and Mineral Metabolism Disorders Treatment Market Overview by Application
3.1 Introduction
3.1.1 Hospital Pharmacies
3.1.2 Retail Pharmacies
3.1.3 Online Pharmacies
3.1.4 Drug Stores
3.2 Global Bone and Mineral Metabolism Disorders Treatment Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Bone and Mineral Metabolism Disorders Treatment Historic Market Size by Application (2018-2023)
3.2.2 Global Bone and Mineral Metabolism Disorders Treatment Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Bone and Mineral Metabolism Disorders Treatment Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Bone and Mineral Metabolism Disorders Treatment Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Bone and Mineral Metabolism Disorders Treatment Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Bone and Mineral Metabolism Disorders Treatment Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Bone and Mineral Metabolism Disorders Treatment Revenue Breakdown by Application (2018-2029)
4 Bone and Mineral Metabolism Disorders Treatment Competition Analysis by Players
4.1 Global Bone and Mineral Metabolism Disorders Treatment Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Bone and Mineral Metabolism Disorders Treatment as of 2022)
4.3 Date of Key Players Enter into Bone and Mineral Metabolism Disorders Treatment Market
4.4 Global Top Players Bone and Mineral Metabolism Disorders Treatment Headquarters and Area Served
4.5 Key Players Bone and Mineral Metabolism Disorders Treatment Product Solution and Service
4.6 Competitive Status
4.6.1 Bone and Mineral Metabolism Disorders Treatment Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Merck
5.1.1 Merck Profile
5.1.2 Merck Main Business
5.1.3 Merck Bone and Mineral Metabolism Disorders Treatment Products, Services and Solutions
5.1.4 Merck Bone and Mineral Metabolism Disorders Treatment Revenue (US$ Million) & (2018-2023)
5.1.5 Merck Recent Developments
5.2 F. Hoffmann-La Roche
5.2.1 F. Hoffmann-La Roche Profile
5.2.2 F. Hoffmann-La Roche Main Business
5.2.3 F. Hoffmann-La Roche Bone and Mineral Metabolism Disorders Treatment Products, Services and Solutions
5.2.4 F. Hoffmann-La Roche Bone and Mineral Metabolism Disorders Treatment Revenue (US$ Million) & (2018-2023)
5.2.5 F. Hoffmann-La Roche Recent Developments
5.3 Novartis
5.3.1 Novartis Profile
5.3.2 Novartis Main Business
5.3.3 Novartis Bone and Mineral Metabolism Disorders Treatment Products, Services and Solutions
5.3.4 Novartis Bone and Mineral Metabolism Disorders Treatment Revenue (US$ Million) & (2018-2023)
5.3.5 Warner Chilcott Recent Developments
5.4 Warner Chilcott
5.4.1 Warner Chilcott Profile
5.4.2 Warner Chilcott Main Business
5.4.3 Warner Chilcott Bone and Mineral Metabolism Disorders Treatment Products, Services and Solutions
5.4.4 Warner Chilcott Bone and Mineral Metabolism Disorders Treatment Revenue (US$ Million) & (2018-2023)
5.4.5 Warner Chilcott Recent Developments
5.5 Sanofi
5.5.1 Sanofi Profile
5.5.2 Sanofi Main Business
5.5.3 Sanofi Bone and Mineral Metabolism Disorders Treatment Products, Services and Solutions
5.5.4 Sanofi Bone and Mineral Metabolism Disorders Treatment Revenue (US$ Million) & (2018-2023)
5.5.5 Sanofi Recent Developments
5.6 AbbVie
5.6.1 AbbVie Profile
5.6.2 AbbVie Main Business
5.6.3 AbbVie Bone and Mineral Metabolism Disorders Treatment Products, Services and Solutions
5.6.4 AbbVie Bone and Mineral Metabolism Disorders Treatment Revenue (US$ Million) & (2018-2023)
5.6.5 AbbVie Recent Developments
5.7 Amgen
5.7.1 Amgen Profile
5.7.2 Amgen Main Business
5.7.3 Amgen Bone and Mineral Metabolism Disorders Treatment Products, Services and Solutions
5.7.4 Amgen Bone and Mineral Metabolism Disorders Treatment Revenue (US$ Million) & (2018-2023)
5.7.5 Amgen Recent Developments
6 North America
6.1 North America Bone and Mineral Metabolism Disorders Treatment Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Bone and Mineral Metabolism Disorders Treatment Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Bone and Mineral Metabolism Disorders Treatment Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Bone and Mineral Metabolism Disorders Treatment Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Bone and Mineral Metabolism Disorders Treatment Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Bone and Mineral Metabolism Disorders Treatment Market Dynamics
11.1 Bone and Mineral Metabolism Disorders Treatment Industry Trends
11.2 Bone and Mineral Metabolism Disorders Treatment Market Drivers
11.3 Bone and Mineral Metabolism Disorders Treatment Market Challenges
11.4 Bone and Mineral Metabolism Disorders Treatment Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
